ACCEPT SIMS AI™

AI-enabled screening intelligence and navigation

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,159
Screening encounters
2,338
Diagnostic referrals
452
Outstanding pathways
192

Screening pathway

  1. Screening2,338Encounters
  2. Positive finding783Documented findings
  3. Referral452Diagnostic referrals
  4. Follow-up500Diagnostic visits
  5. Outcome260Resolved pathways

Stage totals use different units. Pending pathways: 192. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0803 · EXP-0803Synthetic · Site D

Full participant history through 2026-01-16, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Triage · VIA · VIA negative
  4. · Surveillance plan · HPV DNA · HPV positive with negative triage · Scheduled for 2027-11-06

Referral-time risk

No matching referral was available at this observation date.

Screened participants

2159 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-1532 · Expanded synthetic participant 1532Site C — Rural Outreach Programme
EXP-1533 · Expanded synthetic participant 1533Site C — Rural Outreach Programme
EXP-1536 · Expanded synthetic participant 1536Site D — Community Engagement Programme
EXP-1539 · Expanded synthetic participant 1539Site A — Urban Referral Hub
EXP-1540 · Expanded synthetic participant 1540Site E — Resource-Constrained Navigation Programme
EXP-1541 · Expanded synthetic participant 1541Site D — Community Engagement Programme
EXP-1542 · Expanded synthetic participant 1542Site D — Community Engagement Programme
EXP-1544 · Expanded synthetic participant 1544Site D — Community Engagement Programme
EXP-1549 · Expanded synthetic participant 1549Site E — Resource-Constrained Navigation Programme
EXP-1551 · Expanded synthetic participant 1551Site D — Community Engagement Programme
EXP-1552 · Expanded synthetic participant 1552Site A — Urban Referral Hub
EXP-1554 · Expanded synthetic participant 1554Site B — Peri-Urban Access Programme
EXP-1555 · Expanded synthetic participant 1555Site A — Urban Referral Hub
EXP-1557 · Expanded synthetic participant 1557Site A — Urban Referral Hub
EXP-1559 · Expanded synthetic participant 1559Site B — Peri-Urban Access Programme
EXP-1563 · Expanded synthetic participant 1563Site B — Peri-Urban Access Programme
EXP-1567 · Expanded synthetic participant 1567Site E — Resource-Constrained Navigation Programme
EXP-1569 · Expanded synthetic participant 1569Site D — Community Engagement Programme
EXP-1571 · Expanded synthetic participant 1571Site D — Community Engagement Programme
EXP-1581 · Expanded synthetic participant 1581Site D — Community Engagement Programme
EXP-1583 · Expanded synthetic participant 1583Site B — Peri-Urban Access Programme
EXP-1586 · Expanded synthetic participant 1586Site B — Peri-Urban Access Programme
EXP-1589 · Expanded synthetic participant 1589Site C — Rural Outreach Programme
EXP-1590 · Expanded synthetic participant 1590Site B — Peri-Urban Access Programme
EXP-1593 · Expanded synthetic participant 1593Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
985
HPV DNA
1007
Cytology
346

Navigation activity

Barrier documented
380
Contact attempt
663
Navigation intervention
158
Diagnostic booking
554
Diagnostic visit
500

Documented barriers

Contact difficulty
118
Transport difficulty
129
Appointment coordination
133

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.